Flotte TR - Search Results

1

Berns KI, Byrne BJ, Flotte TR, Samulski RJ, Srivastava A. Berns KI, et al. Among authors: flotte tr. Mol Ther. 2023 Mar 1;31(3):607. doi: 10.1016/j.ymthe.2023.01.027. Epub 2023 Feb 10. Mol Ther. 2023. PMID: 36764298 Free PMC article. No abstract available.

2

Nicholas Muzyczka, PhD [1947-2023].

Berns KI, Byrne BJ, Flotte TR, Samulski RJ, Srivastava A. Berns KI, et al. Among authors: flotte tr. Hum Gene Ther. 2023 Feb;34(3-4):81-82. doi: 10.1089/hum.2023.29235.nmu. Hum Gene Ther. 2023. PMID: 36794979 No abstract available.

3

Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.

Song S, Embury J, Laipis PJ, Berns KI, Crawford JM, Flotte TR. Song S, et al. Among authors: flotte tr. Gene Ther. 2001 Sep;8(17):1299-306. doi: 10.1038/sj.gt.3301422. Gene Ther. 2001. PMID: 11571566

4

Transduction of human and mouse pancreatic islet cells using a bicistronic recombinant adeno-associated viral vector.

Kapturczak M, Zolotukhin S, Cross J, Pileggi A, Molano RD, Jorgensen M, Byrne B, Flotte TR, Ellis T, Inverardi L, Ricordi C, Nick H, Atkinson M, Agarwal A. Kapturczak M, et al. Among authors: flotte tr. Mol Ther. 2002 Feb;5(2):154-60. doi: 10.1006/mthe.2002.0522. Mol Ther. 2002. PMID: 11829522 Free article.

5

Improved method of recombinant AAV2 delivery for systemic targeted gene therapy.

Mah C, Fraites TJ Jr, Zolotukhin I, Song S, Flotte TR, Dobson J, Batich C, Byrne BJ. Mah C, et al. Among authors: flotte tr. Mol Ther. 2002 Jul;6(1):106-12. doi: 10.1006/mthe.2001.0636. Mol Ther. 2002. PMID: 12095310 Free article.

6

Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors.

Mohiuddin I, Loiler S, Zolotukhin I, Byrne BJ, Flotte TR, Snyder RO. Mohiuddin I, et al. Among authors: flotte tr. Mol Ther. 2005 Feb;11(2):320-6. doi: 10.1016/j.ymthe.2004.08.030. Mol Ther. 2005. PMID: 15668144 Free article.

7

Adeno-associated virus: a ubiquitous commensal of mammals.

Flotte TR, Berns KI. Flotte TR, et al. Hum Gene Ther. 2005 Apr;16(4):401-7. doi: 10.1089/hum.2005.16.401. Hum Gene Ther. 2005. PMID: 15871671 Review. No abstract available.

8

Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults.

Brantly ML, Spencer LT, Humphries M, Conlon TJ, Spencer CT, Poirier A, Garlington W, Baker D, Song S, Berns KI, Muzyczka N, Snyder RO, Byrne BJ, Flotte TR. Brantly ML, et al. Among authors: flotte tr. Hum Gene Ther. 2006 Dec;17(12):1177-86. doi: 10.1089/hum.2006.17.1177. Hum Gene Ther. 2006. PMID: 17115945 Clinical Trial.

9

Preclinical characterization of a recombinant adeno-associated virus type 1-pseudotyped vector demonstrates dose-dependent injection site inflammation and dissemination of vector genomes to distant sites.

Flotte TR, Conlon TJ, Poirier A, Campbell-Thompson M, Byrne BJ. Flotte TR, et al. Hum Gene Ther. 2007 Mar;18(3):245-56. doi: 10.1089/hum.2006.113. Hum Gene Ther. 2007. PMID: 17376008

10

Charting a clear path: the ASGCT Standardized Pathways Conference.

Kiem HP, Baum C, Bushman FD, Byrne BJ, Carter BJ, Cavagnaro J, Malech HL, Mendell JR, Naldini LM, Sorrentino BP, Williams DA, Flotte TR. Kiem HP, et al. Among authors: flotte tr. Mol Ther. 2014 Jul;22(7):1235-1238. doi: 10.1038/mt.2014.95. Mol Ther. 2014. PMID: 24981438 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

300 results

Search Page